Safety and efficacy of dupilumab in adult atopic dermatitis in Singapore
Introduction:Dupilumab, a biologic approved for treatment of moderate-to-severe atopic dermatitis (AD), has been reported to be largely effective with minimal adverse effects. However, being a targeted therapy, its effectiveness and side effects are expected to be varied in a heterogeneous ethnic po...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wolters Kluwer – Medknow Publications
2026-05-01
|
| Серии: | Singapore Medical Journal |
| Предметы: | |
| Online-ссылка: | https://journals.lww.com/10.4103/singaporemedj.SMJ-2023-031 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|